US Patent D922593 Transcutaneous neuromodulation device
Patent D922593 was granted and assigned to Apex Neuro Holdings, Inc. on June, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent D922593 Transcutaneous neuromodulation device
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
